For instance, PARP1 inhibition suppresses BRD7 PARylation and its ubiquitination degradation, sensitizing BRD7‐positive, rather than BRD7‐negative cancer cells to chemotherapeutic drugs (Hu et al., 2019). Here, PARP1 is linked to cancer.